首页> 外文期刊>International journal of infectious diseases : >Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic
【24h】

Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic

机译:SARS-COV-2抗体在西班牙马略卡岛大学医院的医疗保健工作者中的血清逆转,在Covid-19大流行的第一波浪潮期间

获取原文
       

摘要

Objective To estimate the SARS-CoV-2 antibody seroprevalence in healthcare workers (HCWs) at a university hospital in Mallorca, Spain. Methods All HCWs received an e-mail inviting them to take part in the study. Participants had a nasopharyngeal swab test performed for reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) and serological tests to detect SARS-CoV-2 antibodies (primary study). Additionally, they were invited to complete a questionnaire on their exposure to COVID-19 individuals and their COVID-19-related symptoms (secondary study). Prevalence of antibodies (IgG, IgM, or both) and 95% confidence intervals (CIs) were calculated. Results Seventy-nine percent of the hospital?s HCWs (N = 2210) took part in the primary study. Antibodies were detected in 61 participants, a prevalence of 2.8% (95% CI: 2.5–3.1). The prevalence was slightly higher in nurses (3.4%), registrars (3.9%), and wardens (3.4%). Thirty-nine percent of the primary study participants completed the secondary study questionnaire. Those with positive antibody test results had closer contact with COVID-19 individuals (60% vs. 92%; p 0.001). Conclusion After the first wave of the COVID-19 pandemic in Spain, the seroprevalence of SARS-CoV-2 antibodies in our university hospital HCWs was around 2.8%, which is slightly higher than the seroprevalence in the general population in our region. We believe it would be advisable to perform additional seroprevalence studies during the second wave of the epidemic.
机译:目的估算西班牙马略卡大学医院的医疗保健工人(HCWS)中的SARS-COV-2抗体Seroprence。方法所有HCW都收到了一封邀请他们参加该研究的电子邮件。参与者进行了对逆转录酶定量聚合酶链反应(RT-QPCR)的鼻咽拭子试验和血清学检测以检测SARS-COV-2抗体(初级研究)。此外,他们还被邀请完成对Covid-19个体的接触和他们的Covid-19相关症状(二级研究)的调查问卷。计算抗体(IgG,IgM或两者)和95%置信区间(CIS)的患病率。结果百分之九九的医院?S HCW(n = 2210)参与了初级研究。在61名参与者中检测到抗体,患病率为2.8%(95%CI:2.5-3.1)。护士患病率略高(3.4%),注册商(3.9%)和守望者(3.4%)。 39%的主要研究参与者完成了二级研究问卷。具有阳性抗体试验结果的人与Covid-19个体接触更接近(60%vs.92%; P <0.001)。结论在西班牙的Covid-19大流行病中的第一波浪潮后,我们大学医院HCWS的SARS-COV-2抗体的SEROPREVALING约为2.8%,略高于我们地区一般人群的SEROPREVALING。我们认为,建议在疫情的第二波期间进行额外的血清普朗研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号